Skip to content
AnzuPartners
  • About
  • Solutions
    • Debt and Revenue-Based Investments
    • Special Purpose Acquisition Companies (SPACs)
  • Press
  • Resources
    • Newsletter
    • Newsroom
  • Contact
    • Company Questionnaire
  • Team
  • Talent
  • About
  • Solutions
    • Debt and Revenue-Based Investments
    • Special Purpose Acquisition Companies (SPACs)
  • Press
  • Resources
    • Newsletter
    • Newsroom
  • Contact
    • Company Questionnaire
  • Team
  • Talent

NUBURU Announces a Second Contract With NASA for Next-Generation Blue Laser Space Technology

NASA and NUBURU to Demonstrate the Feasibility of Surface Power Management Solutions Using Blue Laser Technology

South 8 Partners with NanoGraf on $6.4M U.S. Army Contract to Advance Domestic Lithium-ion Battery Production

Joint project will develop Family of Advanced Standard Batteries (FAStBat) to power military platforms

GelSight’s New AI-Enhanced Metrology Software Streamlines Integration with Partner Solutions

New GelSight Mobile 3.7 software update introduces new API integration and Mandarin translation support to enhance customers’ global workflows

6K Energy Announces IRA Compliant LFP and NMC Lithium-Ion Cathode Active Material (CAM) for North American Battery Production

Actively being sampled by major OEMs, battery material from plasma production enables costs lower than China with more than 50% lower carbon footprint over conventional methods

Anzu Partners Promotes Three Business Services Team Members to Principal

Patrick Harrington, Kyle McQuighan, and Wendy Papakostandini are promoted to Principal for their work to advance Anzu Partners’ fund finance, capital solutions, and talent

Excision BioTherapeutics to Present Positive Data from its HSV-1 Keratitis Program, EBT-104, at the ASGCT 2024 Annual Meeting

ASGCT presentation will include positive data from herpes simplex virus-1 keratitis program, EBT-104, as well as an overview of a next-generation AAV delivery vector

Excision BioTherapeutics Announces Oral Presentation Highlighting Positive Data from its HBV Program, EBT-107, at the Upcoming ASGCT 2024 Annual Meeting

Oral presentation to highlight proof-of-concept efficacy in reducing HBV biomarkers in serum and intrahepatic HBV in vivo

Excision BioTherapeutics Announces Oral Presentation of Preclinical HSV-1 Keratitis Data at CRISPRMED24 Conference on April 24, 2024

Treatment with EBT-104 resulted in over 90% reduction in viral shedding in HSV-1 Keratitis model

Xendee’s Small Modular Reactor Modeling Shows Significant Carbon Reduction for University of Illinois Urbana-Champaign

The landscape of the electricity grid is rapidly evolving. The University of Illinois Urbana-Champaign (UIUC) and Xendee Corporation (Xendee) have teamed up to lead this transformation.

Anzu Partners Sponsors First U.S. High Tech Venture Days (HTVD)

America and Europe’s finest hard tech startups to pitch at HTVD in Washington, D.C on May 7-8.

← Previous
Next →

QUICK LINKS

About

Portfolio

Team

RESOURCES

Press Releases

Newsroom

Newsletter

GET IN TOUCH

Company Questionnaire

Talent

Contact Us

Investor Portal

CONNECT WITH US

Twitter Linkedin

© 2025 Anzu Partners

Privacy Policy

Supplier Code of Business Conduct

We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking “Accept”, you consent to the use of ALL the cookies.
Cookie settingsACCEPT
Privacy & Cookies Policy

Privacy Overview

This website uses cookies to improve your experience while you navigate through the website. Out of these cookies, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may have an effect on your browsing experience.
Necessary
Always Enabled
Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.
Non-necessary
Any cookies that may not be particularly necessary for the website to function and is used specifically to collect user personal data via analytics, ads, other embedded contents are termed as non-necessary cookies. It is mandatory to procure user consent prior to running these cookies on your website.
SAVE & ACCEPT